Holen Sie sich die Stockscreener-App
294.43
0.67%
1.95
Handel nachbörslich:
294.81
0.38
+0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$292.48
Offen:
$294.09
24-Stunden-Volumen:
2.37M
Relative Volume:
1.03
Marktkapitalisierung:
$66.30B
Einnahmen:
$189.25B
Nettoeinkommen (Verlust:
$5.35B
KGV:
12.53
EPS:
23.5
Netto-Cashflow:
$5.34B
1W Leistung:
+6.56%
1M Leistung:
-13.57%
6M Leistung:
-24.81%
1J Leistung:
-44.62%
1-Tages-Spanne:
$291.57
$298.91
1-Wochen-Bereich:
$278.20
$299.45
52-Wochen-Spanne:
$273.71
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
294.43 | 65.86B | 189.25B | 5.35B | 5.34B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 236.90B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 83.09B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 74.87B | 261.22B | 5.40B | 3.94B | 18.32 |
|
HUM
Humana Inc
|
281.99 | 33.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Uncertainty Rising at Elevance Primarily on Challenges in Medicaid and Individual Exchanges - Morningstar
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline - MSN
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion - The Globe and Mail
Anthem Blue Cross Commercial and Exchange Health Plans Awarded NCQA Health Equity Accreditation in California - Business Wire
Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT - MSN
Barrow, Hanley, Mewhinney & Strauss Reduces Stake in Elevance Health Inc by 54.26% - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
When a Healthcare Giant Gets Sick: Elevance Health’s 20% YTD Decline - InsuranceNewsNet
Is Elevance Health Inc. a turnaround storyDouble in 10 Days Stock Ideas - thegnnews.com
The Power of Personalized Care During Pregnancy - www.elevancehealth.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Investors to Inquire about Securities Investigation - ACCESS Newswire
Baird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral - MSN
Mizuho Securities Maintains Buy Rating on Elevance Health with $342 Price Target - AInvest
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
UBS Affirms Elevance Health’s (ELV) ‘Buy’ Rating on Earning Stability and Growth Prospects - Insider Monkey
Baird Lowers Elevance Health Price Target to $297, Maintains Neutral Rating. - AInvest
Iowa House panel dismisses ethics complaint over lobbying on PBM bill - The Des Moines Register
Meta Platforms and Elevance Health have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: Elevance Health (ELV) - The Globe and Mail
Bear Of The Day: Elevance Health (ELV) - Barchart.com
Is it the right time to buy Elevance Health Inc. stockFree Stock Market Trend Analysis - Jammu Links News
When is Elevance Health Inc. stock expected to show significant growthDynamic investment opportunities - Jammu Links News
How strong is Elevance Health Inc. company’s balance sheetCapitalize on market opportunities with confidence - Jammu Links News
Is Elevance Health Inc. stock overvalued or undervaluedFree Risk Assessment Services - Jammu Links News
Should I hold or sell Elevance Health Inc. stock in 2025Proven strategies for superior portfolio growth - Jammu Links News
What are Elevance Health Inc. company’s key revenue driversAchieve consistent double-digit growth - Jammu Links News
Why is Elevance Health Inc. stock attracting strong analyst attentionInvest confidently with real-time data - Jammu Links News
What are analysts’ price targets for Elevance Health Inc. in the next 12 monthsUnlock daily market insights for better decisions - Jammu Links News
Insider Activity at Elevance Health: A Tale of Confidence and Cautious Diversification - AInvest
Elevance Health Insiders Sell US$6.7m Of Stock, Possibly Signalling Caution - Yahoo Finance
Trapped Investors in Elevance Health Inc. Await Breakout SignalMarket Entry and Exit Point Tips From Traders - metal.it
Elevance Health stock hits 52-week low at $274.33 - Investing.com Australia
Elevance Health stock hits 52-week low at $274.33 By Investing.com - Investing.com India
UnitedHealth replaces CFO Rex in another management shake-up - Reuters
Peter Lynch's Top Health Care Stocks Based on Validea: Elevance Health and UFP Technologies - AInvest
Why Elevance Health Inc. stock attracts strong analyst attentionSwing Setup With Technical Confirmation Explained - metal.it
Positive Sentiment Still Eludes Elevance Health, Inc. (NYSE:ELV) Following 25% Share Price Slump - simplywall.st
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Elevance Health Board Appoints Steve Collis As Director - citybiz
Momentum Screeners Rank Elevance Health Inc. in Top 5 TodayRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs - MSN
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - The Globe and Mail
Medicare Advantage in 2025: Enrollment Update and Key Trends - KFF
Elevance Health (ELV) Receives Buy Rating from UBS with Optimistic EPS Forecast - GuruFocus
Elevance Health, Inc: A Deeply Undervalued Long-Term OpportunityF.A.S.T. GraphsCommentaries - Advisor Perspectives
Is Elevance Health Inc. a growth stock or a value stockGet daily updates on promising stocks - jammulinksnews.com
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):